We are live on ! Find out more
PP

PDT Partners Portfolio holdings

AUM $1.69B
1-Year Est. Return 74.01%
This Fund
S&P 500
This Quarter Est. Return
+8.44%
1 Year Est. Return
+74.01%
3 Year Est. Return
+179.69%
5 Year Est. Return
+210.81%
10 Year Est. Return
+1,321.68%
AUM
$618M
AUM Growth
-$43.1M
Cap. Flow
-$63.8M
Cap. Flow %
-10.32%
Top 10 Hldgs %
7.4%
Holding
973
New
156
Increased
203
Reduced
222
Closed
372

Top Buys

Rank Stock Value
1
GH icon
Guardant Health
GH
+$3.94M
2
MRSH
Marsh
MRSH
+$3.18M
3
DXC icon
DXC Technology
DXC
+$3.13M
4
WAT icon
Waters Corp
WAT
+$3.01M
5
DPZ icon
Domino's
DPZ
+$2.73M

Top Sells

Rank Stock Value
1
HON icon
Honeywell
HON
+$3.17M
2
ATKR icon
Atkore
ATKR
+$3.17M
3
ANET icon
Arista Networks
ANET
+$3.02M
4
ENPH icon
Enphase Energy
ENPH
+$3M
5
EVH icon
Evolent Health
EVH
+$2.97M

Sector Composition

Rank Sector Weight
1 Technology 21.23%
2 Healthcare 18.83%
3 Financials 14.91%
4 Industrials 13.43%
5 Consumer Discretionary 10.45%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
X
251
DELISTED
US Steel
X
$908K 0.15%
+36,244
New +$836K
BXC icon
252
BlueLinx
BXC
$430M
$904K 0.15%
12,715
-414
-3% -$28.2K
NMRK icon
253
Newmark Group
NMRK
$2.64B
$904K 0.15%
113,444
+88,065
+347% +$734K
TRMD icon
254
TORM
TRMD
$3.05B
$895K 0.14%
31,336
-23,048
-42% -$621K
BBIO icon
255
BridgeBio Pharma
BBIO
$16.4B
$894K 0.14%
117,292
-9,001
-7% -$86.2K
PTGX icon
256
Protagonist Therapeutics
PTGX
$8.55B
$893K 0.14%
81,835
-44,203
-35% -$373K
SSRM icon
257
SSR Mining
SSRM
$5.19B
$888K 0.14%
+56,699
New +$831K
AMPL icon
258
Amplitude
AMPL
$1.18B
$883K 0.14%
73,067
+49,217
+206% +$697K
FCF icon
259
First Commonwealth Financial
FCF
$2.22B
$882K 0.14%
63,146
+4,990
+9% +$70.3K
COUR icon
260
Coursera
COUR
$1.77B
$876K 0.14%
74,052
+9,369
+14% +$118K
LECO icon
261
Lincoln Electric
LECO
$14.1B
$874K 0.14%
+6,050
New +$849K
AMAT icon
262
Applied Materials
AMAT
$347B
$867K 0.14%
8,904
-5,296
-37% -$508K
CNM icon
263
Core & Main
CNM
$7.93B
$863K 0.14%
44,683
+7,378
+20% +$157K
CPRI icon
264
Capri Holdings
CPRI
$1.82B
$859K 0.14%
14,984
+22
+0.1% +$1.11K
LILAK icon
265
Liberty Latin America Class C
LILAK
$1.69B
$858K 0.14%
124,154
+27,113
+28% +$186K
IOT icon
266
Samsara
IOT
$22.6B
$857K 0.14%
68,932
-66
-0.1% -$751
ARQT icon
267
Arcutis Biotherapeutics
ARQT
$3.48B
$857K 0.14%
57,877
+45,204
+357% +$790K
HIBB
268
DELISTED
Hibbett, Inc. Common Stock
HIBB
$851K 0.14%
12,469
-21,004
-63% -$1.31M
NVMI
269
Nova
NVMI
$11.7B
$850K 0.14%
10,408
+2
+0% +$163
IBTX
270
DELISTED
Independent Bank Group, Inc.
IBTX
$850K 0.14%
14,141
+6,707
+90% +$426K
AME icon
271
Ametek
AME
$53.9B
$849K 0.14%
+6,080
New +$806K
SNCY
272
DELISTED
Sun Country Airlines
SNCY
$849K 0.14%
+53,514
New +$938K
TGI
273
DELISTED
Triumph Group
TGI
$848K 0.14%
+80,570
New +$833K
SMAR
274
DELISTED
Smartsheet Inc.
SMAR
$843K 0.14%
21,411
-6,030
-22% -$205K
THG icon
275
Hanover Insurance
THG
$8.13B
$840K 0.14%
6,216
+778
+14% +$109K

Similar funds

PDT Partners's Q4 2022 Portfolio in Review

As of Q4 2022, PDT Partners held 973 positions worth $618M, down 6.5% from $661M the previous quarter. Its ten largest holdings account for 7.4% of the portfolio.

PDT Partners withdrew a net $63.8M in Q4 2022, closing 372 positions and reducing 222 holdings. Its most notable exit was Honeywell, an estimated $3.17M position sold in full.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 21% a quarter earlier, followed by Healthcare and Financials.

Against the trend, PDT Partners opened a new position in Guardant Health worth $2.34M.

  • PDT Partners's largest Q4 2022 buy was Guardant Health: 86,159 shares worth $2.34M.
  • PDT Partners added most to Waters Corp in Q4 2022, an estimated $3.01M increase.
  • PDT Partners's biggest Q4 2022 reduction was Enphase Energy, cutting an estimated $3M.
  • PDT Partners fully exited Honeywell in Q4 2022, selling an estimated $3.17M.
  • PDT Partners's ten largest holdings make up 7.4% of its $618M portfolio in Q4 2022.
  • PDT Partners opened 156 new positions and closed 372 in Q4 2022.
  • PDT Partners's portfolio value fell 6.5% quarter-over-quarter to $618M.

Based on PDT Partners's 13F filing for Q4 2022, filed 14 Feb 2023.